FDA Investigator: Christopher M. Cox
- Christopher M. Cox first started conducting FDA inspections in 2018, with the last inspection in 2023. Over that time, Christopher M. Cox has conducted 19 inspections at 12 companies across 19 sites.
Get Christopher Cox's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 BioLife Plasma Services LP, Milwaukee | 2023
Out-of-stock
Christopher M. Cox
Biologics Form 483
FDA 483 CSL Plasma Inc., Las Vegas | 2023
Out-of-stock
Christopher M. Cox
Biologics Form 483
FDA 483 Octapharma Plasma Inc, Houston | 2023
Out-of-stock
Christopher M. Cox
Biologics Form 483
FDA 483 B Positive National Blood Services - Cheltenham LLC, Wyncote | 2022
Out-of-stock
Christopher M. Cox
Biologic Form 483
FDA 483 BPL Plasma Inc, El Paso | 2019
Out-of-stock
Christopher M. Cox
Biologic Form 483
FDA 483 BPL Plasma Inc, El Paso | 2019
Out-of-stock
Christopher M. Cox
Biologic Form 483
FDA 483 KEDPLASMA LLC, Atlanta | 2019
Out-of-stock
Christopher M. Cox
Biologic Form 483
Co-Investigators (9)
- Eric T. Huebler, FDA Investigator
- Miriam Montes, FDA Investigator
- Catherine L. McGraw, FDA Investigator
- Thaddeus N. Nnabue, FDA Investigator
- Carmelita F. Bibby, FDA Investigator
- Everard A. Irish, FDA Investigator
- Judy E. Ciaraldi, FDA Investigator
- Cordelia J. Brammer, FDA Investigator
- Bryce A. May, FDA Investigator